Fresh analysis reveals that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Research printed in a prominent health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these drugs must be cognizant of the risk of rapid rebound weight gain when the treatment ends," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to original weight within about a year and a half.
Weighing Therapies
The analysis, which looked at 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.
The team point out that people who shed pounds through dieting typically have a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Explaining the Quick Rebound
Experts propose the way of the drugs is key to understanding the amplified regain.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating a significant risk."
An Ongoing Issue?
Health authorities suggest the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts say that, due to the likelihood of weight regain, the therapy is often life-long.
This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic nature of obesity," akin to managing diseases like diabetes.
User Experiences
Individuals who have stopped the medication explain a sudden return of hunger.
"I experienced something that goes on and you become ravenous," recalled an individual.
The struggle is exacerbated if patients have not established sustainable lifestyle or habit changes during therapy.
Growing Adoption
Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle support.
